government
-
US government HIV/AIDS clinical trial sites to accelerate completion of Phase III TB drug trial
The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases’ (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.
government | 09 January 2012
-
Paromomycin added to national essential medicines list by government of Nepal
OneWorld Health (OWH) announced that its antibiotic paromomycin (PMIM) a life-saving medicine for the treatment of Kala-Azar (black fever), has been approved for the Essential Drug List of Nepal. This milestone signifies a major vote of confidence fr…
government | 17 August 2011
-
Lipocine Chairman awarded “Order of the Rising Sun†by Japanese government
Lipocine announces that Dr William Higuchi, Lipocine co-founder and Chairman of the Board, was awarded the ‘Order of The Rising Sun’ by the Japanese Government for “contribution to the development of Japanese pharmaceutics and pharmaceutical ch…
government | 07 July 2011
-
Optimism over Australia election
Lisette Oversteegen, lead analyst from Datamonitor , comments on the impact of Australia’ election. Now that the Labor party has claimed a narrow victory, the pharmaceutical industry has reason to be optimistic about the Memorandum of Understand…
government | 22 September 2010
-
Agilent signs agreement with Malaysian government
Agilent Technologies signs a memorandum of understanding (MoU) with the Government of Malaysia through the Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPHARM), an agency under the Ministry of Science, Technology and Innovation (MOSTI)…
government | 23 August 2010
-
GlaxoSmithKline: Government Orders for Pandemic (H1N1) 2009 Vaccine
GlaxoSmithKline (GSK) has confirmed that it has contracts in place to supply 195 million doses of its pandemic (H1N1) 2009 adjuvanted influenza vaccine. It has a variety of agreements in place with the US government to supply pandemic products worth …
government | 10 August 2009
-
Australian Government Stockpiles 1.6 million Courses of Relenza
Biota Holdings has announced that the Australian government has purchased an additional 1.6 million courses of Relenza for the National Medical Stockpile to bolster supplies of antiviral drugs to treat pandemic influenza. The purchase cost is A$43 mi…
government | 08 June 2009
-
Sanofi Pasteur Lands US$190 Million Order from the US Government
Sanofi Pasteur has received the first of what is expected to be a series of orders from the US Department of Health and Human Services (HHS) to commence production of an influenza A(H1N1) vaccine. This order from HHS was issued pursuant to an exis…
government | 29 May 2009
-
Intergovernmental Meeting On Pandemic Influenza Preparedness
The Member States of the World Health Organization (WHO) has met in Geneva from 20-23 November to discuss the sharing of influenza viruses and the benefits of such cooperation, which include access to vaccines. This meeting follows an August 2007 …
government | 30 November 2007
-
Government Fosters Malaysian Biotech
Malaysia is developing centers of excellence and fighting brain drain as it works to establish itself as a biotech hotbed.
government | 01 December 2006
